FDA Drug Recalls

Recalls / Class II

Class IID-0210-2018

Product

Codeine-Guaifenesin Oral Solution 10-100 mg/5 mL Antitussive Expectorant ,16 fl. oz. , Manufactured For: Method Pharmaceuticals, LLC Arlington, TX 76006, NDC 58657-500-16

Brand name
Codeine-guaifenesin
Generic name
Codeine Phosphate And Guaifenesin
Active ingredients
Codeine Phosphate, Guaifenesin
Route
Oral
NDC
58657-500
FDA application
M012
Affected lot / code info
Lot: 08616; Exp. 07/18

Why it was recalled

Microbial Contamination of Non-Sterile Products: potentially contamination with the bacteria Burkholderia cepacia

Recalling firm

Firm
Woodfield Pharmaceutical, LLC
Manufacturer
Method Pharmaceuticals, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10863 Rockley Rd, N/A, Houston, Texas 77099-3405

Distribution

Quantity
15,707 bottles
Distribution pattern
Texas

Timeline

Recall initiated
2017-12-12
FDA classified
2018-01-08
Posted by FDA
2018-01-17
Terminated
2020-01-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0210-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.